This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John S. Bradley, MD; John F. Bastian, MD; James D. Connor, MD
University of California Children's Hospital San Diego

JAMA. 1989;262(14):1948.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor. —

We differ with an opinion expressed in THE JOURNAL on April 7 regarding health care worker exposure to ribavirin, an antiviral agent with in vitro activity against respiratory syncytial virus (RSV).¹ Data regarding the efficacy of this agent in the treatment of RSV infections in children have been published.^2,3 Guidelines for the use of this drug have been published by the American Academy of Pediatrics.⁴ Faculty from the Department of Pediatrics, University of California, San Diego, and Children's Hospital, San Diego, were faced with the same concerns regarding health care worker safety as those expressed by Guglielmo et al.¹ The Pharmacy and Therapeutics Committee of Children's Hospital appointed a similar task force from the University of California and Children's Hospital composed of representatives from the Divisions of Infectious Diseases, Pulmonary Medicine, General Pediatrics, and Pharmacy to discuss these issues as well as . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?